Kadowaki T, Seino Y, Kaku K, Okamoto T, et al. A Randomized, Placebo-controlled Study to Evaluate the Efficacy and Safety of
Adding Omarigliptin to Insulin Therapy in Japanese Patients with Type 2 Diabetes
and Inadequate Glycemic Control. Diabetes Obes Metab 2021 Jan 29. doi: 10.1111/dom.14331.
PMID: 33512755